Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jmv.27037 http://scihub22266oqcxt.onion/10.1002/jmv.27037 33913544!8242373!33913544     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Med+Virol 2021 ; 93 (9): 5608-5613 Nephropedia Template TP {{tp|p=33913544|t=2021. Characterization of T lymphocytes in severe COVID-19 patients |pdf=|usr=}}{{33913544}} gab.com Text Characterization of T lymphocytes in severe COVID-19 patients JO: J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=33913544 #FOAvip In this observational study, 13 patients with severe COVID-19 and 10 healthy controls were enrolled. The data concerning the analysis of circulating T cells show that, in severe COVID-19 patients, the expansion of these cell compartments is prone to induce antibody response, inflammation (CCR4+ and CCR6+ TFH) and regulation (CD8+ Treg). This pathogenic mechanism could lead us to envision a possible new form of biological target therapy. Twit Text FOAVip Characterization of T lymphocytes in severe COVID-19 patients ????J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=33913544 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33913544 #FOAvip English Wikipedia <ref>{{Cite pmid|33913544}}</ref> Characterization of T lymphocytes in severe COVID-19 patients #MMPMID33913544 Fenoglio D; Dentone C; Parodi A; Di Biagio A; Bozzano F; Vena A; Fabbi M; Ferrera F; Altosole T; Bruzzone B; Giacomini M; Pelosi P; De Maria A; Bassetti M; De Palma R; Filaci G J Med Virol 2021[Sep]; 93 (9): 5608-5613 PMID33913544show ga In this observational study, 13 patients with severe COVID-19 and 10 healthy controls were enrolled. The data concerning the analysis of circulating T cells show that, in severe COVID-19 patients, the expansion of these cell compartments is prone to induce antibody response, inflammation (CCR4+ and CCR6+ TFH) and regulation (CD8+ Treg). This pathogenic mechanism could lead us to envision a possible new form of biological target therapy. |Adaptive Immunity[MESH] |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Antibodies, Viral/*biosynthesis/immunology[MESH] |CD4-Positive T-Lymphocytes/immunology[MESH] |CD8-Positive T-Lymphocytes/*immunology[MESH] |COVID-19/*immunology[MESH] |Case-Control Studies[MESH] |Female[MESH] |Fluorescent Antibody Technique[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Receptors, CCR4[MESH] |Receptors, CCR6[MESH]Characterization of T lymphocytes in severe COVID-19 patients (epmc).pdf DeepDyve Pubget Overpricing